ClinicalTrials.Veeva

Menu

Effect of CI on Prognosis in the Elderly Patients With ACS (CIACS)

Capital Medical University logo

Capital Medical University

Status

Unknown

Conditions

Cognitive Impairment
Acute Coronary Syndrome
Elderly

Treatments

Diagnostic Test: MMSE and MoCA

Study type

Observational

Funder types

Other

Identifiers

NCT04278911
BFH--CI and ACS

Details and patient eligibility

About

This study aims to investigate the incidence and characteristics of cognitive Impairment(CI) in the elderly patients with acute coronary syndrome (ACS), and to determine whether CI are predictive of the prognosis of major adverse cardiovascular events (MACE) and mortality.

Enrollment

500 estimated patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ≥65yr
  • Confirmed ACS diagnosis (include unstable angina, ST-segment elevation myocardial infarction and Non ST-segment elevation myocardial infarction)
  • fulfilled MMSE or MoCA
  • patients agreed and provided informed consent

Exclusion criteria

  • Type 2 myocardial infarction and Acute nonischemic myocardial injury
  • past history of malignant tumors
  • Past history of stroke or dementia
  • Hepatic insufficiency (ALT>8ULN or ALT>3ULN and TBIL>2ULN)
  • Renal insufficiency (GFR<15 ml/min/1.73m2)

Trial design

500 participants in 1 patient group

Participates
Description:
This is an observational study
Treatment:
Diagnostic Test: MMSE and MoCA

Trial contacts and locations

1

Loading...

Central trial contact

Hongwei Li, Prof.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems